Situation:

• Stem cell client engaged KCSA to assist with introductions to the institutional investment community; the goal for financing at higher valuation within the year.

Strategies / Tactics:

• Overhauled investor relations (IR) program through a new messaging strategy to educate the market on client’s business model.
• Secured conference participation.
• Arranged non-deal roadshows and 1x1 conference call introductions.

Results:

• 467 buy-side introductions (with feedback).
• 55 or 12% of buy-side introductions took a 1x1 meeting or call.
• An additional 50 or 11% expressed an interest in a 1x1 meeting or call with management in the future.
• 105 or 23% took at 1x1 call/meeting or are pending a call/meeting.
• Two funds whom KCSA connected with management filed publicly their ownership.
• During engagement, management closed on an underwritten equity financing for $20 million.

Situation:

• Clinical-stage biopharmaceutical company engaged KCSA to develop and execute a targeted communications program highlighting its science and clinical success, which helped raise the company’s profile amongst key target audiences and acted as a vehicle to support its capital markets activities.

Strategies / Tactics:

• KCSA successfully launched a two-stage communications program that executed on the following:
  • Stage I: Comms. plan was primarily geared toward raising the company’s profile with the scientific community.
  • Stage II: Comms. plan capitalized on the success of our science and trade-focused comms program to increase the company’s profile with top-tier business/finance media.

Results:

• Established deep relationships with key scientific trades and financial media.
• Positioned the CEO as a go-to resource for the media and highlighted the company’s unique approach to cancer treatment.